PSN 059
PSN 059, licence 80007113: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Veevance Inc.
- NPN or DIN-HM
- 80007113
- Status
- Inactive licence
- Licence date
- 13 August 2008
- Revision date
- 7 July 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 3.0 Jour(s) |
Uses authorised in Canada
Utilisée traditionnellement en phytothérapie pour aider à dormir.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de santé si les symptômes persistent ou s'aggravent. Consulter un praticien de soins de santé si l'insomnie persiste au-delà de trois (3) semaines. Consulter un praticien de soins de santé avant d'en faire l'usage si vous êtes enceinte ou si vous allaitez. La consommation de la passiflore en association avec des breuvages alcoolisés ou tout autre médicament ou produit de santé naturel ayant des effets sédatifs es déconseillée.
- Effets indésirables connus
Une hypersensibilité (e.g. une allergie) peut se manifester. Si tel est le cas, cesser l'utilisation. Certaines personnes pourraient éprouver de la somnolence. Faire preuve de prudence si vous conduisez de la machinerie lourde ou tout autre véhicule motorisé, ou si vous devez entreprendre des activités qui requièrent de la vigilance.
Source
Official Health Canada record, licence 80007113
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.